An openly cooperative constructive dialogue prevailed at the 9 July 2009 annual meeting of BIO and CDE experts, further heightened by the active participation of the two directors, Messrs Hugo Bosmans and Mabousso Thiam, who closed the meeting by signing the addendum which extends for three years the first cooperation framework agreement signed by the two organizations on 6 April 2006.

CASEIF II recently completed its investment in TECNOSOLUCION S.A. (TECNOSOL). The investment’s main purpose is to support the company’s growth strategy in Nicaragua and to start the regional expansion plan in Central America. This project demonstrates how BIO’s investments in private equity funds such as CASEIF II can yield very high development effects by contributing to the expansion of small businesses in the region.

BIO, the Belgian Investment Company for Developing Countries has published its 2008 annual report. Its investment portfolio has increased significantly and net profits have reached 2.900 million Euros. On 31st December 2008, BIO net commitments stood at 172.9 million Euros, which represented an increase of 31% compared with 2007 (125.5 million Euros) at a constant USD/EUR rate.

The European Investment Bank (EIB) and the European Development Finance Institutions (EDFI) today agreed to replenish the co-financed facility EUROPEAN FINANCING PARTNERS with €230 million to finance private sector investments in Africa, the Caribbean and the Pacific (ACP).

The reputation and performance of Banco de Crédito Centroamericano, BANCENTRO, a member of the LAFISE Group, has been reaffirmed once again, obtaining three important long-term subordinated loans totaling $15 million dollars to support the main economic and productive sectors of Nicaragua. These agreements are even more valuable and significant now that the global markets have been constrained due to the financial crisis affecting economies worldwide.